Burry
No longer files. Scion Asset Management deregistered as an investment adviser on November 10, 2025 and no longer files Form 13F; the Q3 2025 book is its last.
Q3 2025 versus Q2 2025: 7 bought, 1 added to, 0 reduced, 14 sold. By dollars, the largest buy was Palantir, $912.1M more at the quarter-end price; the largest sale UnitedHealth, $109.2M less. Net, $805.8M more bought than sold. What every tracked investor did in Q3 2025.
Every move, largest first
| Ticker | Issuer | Move | Shares Q2 2025 → Q3 2025 | Bought / sold | Of the portfolio | Weight now | Price vs model |
|---|---|---|---|---|---|---|---|
| PLTR | Palantir Technologies INC (Put) | bought | — → 5.0M | +$912.1M | +66.04% | 66.0% | — |
| NVDA | Nvidia Corporation (Put) | bought | — → 1.0M | +$186.6M | +13.51% | 13.5% | — |
| PFE | Pfizer INC (Call) | bought | — → 6.0M | +$152.9M | +11.07% | 11.1% | — |
| UNH | Unitedhealth Group INC (Call) | sold | 350,000 → 0 | −$109.2M | −7.91% | — | — |
| REGN | Regeneron Pharmaceuticals (Call) | sold | 200,000 → 0 | −$105.0M | −7.60% | — | — |
| LULU | Lululemon Athletica INC (Call) | sold | 400,000 → 0 | −$95.0M | −6.88% | — | — |
| META | Meta Platforms INC (Call) | sold | 100,000 → 0 | −$73.8M | −5.34% | — | — |
| HAL | Halliburton CO (Call) | bought | — → 2.5M | +$61.5M | +4.45% | 4.5% | — |
| EL | Lauder Estee Cos INC (Call) | sold | 500,000 → 0 | −$40.4M | −2.92% | — | — |
| JD | Jd.com INC (Call) | sold | 1.0M → 0 | −$32.6M | −2.36% | — | — |
| BABA | Alibaba Group Hldg LTD (Call) | sold | 250,000 → 0 | −$28.4M | −2.05% | — | — |
| MOH | Molina Healthcare INC | bought | — → 125,000 | +$23.9M | +1.73% | 1.7% | — |
| ASML | Asml Holding N V (Call) | sold | 25,000 → 0 | −$20.0M | −1.45% | — | — |
| VFC | V F Corp (Call) | sold | 1.5M → 0 | −$17.6M | −1.28% | — | — |
| SLM | Slm Corp | bought | — → 480,054 | +$13.3M | +0.96% | 1.0% | — |
| BRKR 6.375 09/01/28 | Bruker Corp | bought | — → 48,334 | +$13.1M | +0.95% | 1.0% | — |
| EL | Lauder Estee Cos INC | sold | 150,000 → 0 | −$12.1M | −0.88% | — | — |
| BRKR | Bruker Corp | sold | 250,000 → 0 | −$10.3M | −0.75% | — | — |
| LULU | Lululemon Athletica INC | added +100% | 50,000 → 100,000 | +$8.9M | +0.64% | 1.3% | 53% undervalued |
| REGN | Regeneron Pharmaceuticals | sold | 15,000 → 0 | −$7.9M | −0.57% | — | — |
| MELI | Mercadolibre INC | sold | 3,000 → 0 | −$7.8M | −0.57% | — | — |
| UNH | Unitedhealth Group INC | sold | 20,000 → 0 | −$6.2M | −0.45% | — | — |
Bought / sold is the change in shares × the quarter's reported price (value ÷ shares in the filing); a position sold out is priced at the quarter before, since it has no price in this one. “Of the portfolio” is that amount against this quarter's reported book.
Source: the manager's Form 13F-HR on SEC EDGAR, kept as immutable quarterly snapshots; changes compare two consecutive filings. A 13F is filed up to 45 days after quarter end and covers US-listed long positions only. Tickers come from a self-maintained CUSIP map; a position without one shows its CUSIP. Method notes in where the numbers come from.